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Abstract
Introduction
The rise of antibiotic resistance is a global health threat requiring 
development of novel treatments. β-lactamase enzymes found in 
many multi-drug resistant bacteria contribute to resistance of β-
lactam antibiotics. The enzyme cleaves the β-lactam ring, preventing 
the drug from reaching its cellular target. A class of β-lactamases, 
Acinetobacter-derived cephalosporinases (ADCs) are found in the 
multi-drug resistant bacteria Acinetobacter baumannii. Specific 
ADCs were selected from a group of antibiotic-resistant infections. 
With no known structures of these newly identified ADCs, it is key to 
discern how minor differences in sequences between ADCs 
contribute to drug resistance. In this project, structural and kinetics 
characterization of ADCs will aim to develop a relationship on how 
small structural variations can affect the enzyme’s ability to bind and 
destroy antibiotics. These results will help identify potential 
inhibitors against enzymes that contribute to antibiotic resistance.
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Porin Channel• β-lactam antibiotics 
work by binding to the 
enzyme transpeptidase, 
which is found in the 
cell wall of the bacteria
• The binding of the 
antibiotic causes the 
bacterial cell to lyse 
open from osmotic 
pressure as the 
antibiotic inhibits cell 
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Results
Conclusions and Future Directions
Conclusions
The slight changes between the genetic sequences of ADC-7 and the 
variants may have lead to  changes in the ADC variant structure that 
allows them to bind to a wider range of antibiotics. Thus, it is crucial to 
characterize the structures that were obtained and determine what 
structural differences exist between ADC-7 and the variants. 
Identifying these differences is necessary as it ensure that potential 
inhibitors are developed for enzymes that have been found in recently 
infected individuals and will be applicable for treatment.
Future Directions
▪ Determine the crystal structures of the ADC variants and 
investigate how these differences enable bacteria to be resistant to 
more types of antibiotics.
▪ Complete kinetics to measure the Ki values for all ADC variants. 
▪ Attempt to identify ideal crystal growing conditions for ADC-25 
A200D/P220L/Ainsert crystals.
▪ The end goal of the project is to identify potential Boronic Acid 
Transition State Inhibitors (BATSIs), such as MB076, that can be 
used in tandem with β-lactam antibiotics to work against bacteria.
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Methods
ADC-30 ADC-33ADC-68 ADC-25
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37 kDa
MW MW
• β-lactamases serve as one mechanism of bacteria that contribute 
towards antibiotic resistance
• β-lactamase enzymes bind and hydrolyze β-lactam antibiotics, 
cleaving the β-lactam ring and making them inactive
• The antibiotic is now unable to inhibit cell wall biosynthesis
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• Antibiotic resistance is a growing concern and viewed as a global 
health problem, necessitating the development of novel alternative 
treatments to combat bacterial resistance towards antibiotics.
• Antibiotic resistance occurs in the bacteria Acinetobacter 
baumannii, which is an opportunistic bacterial pathogen. The 
bacteria is labeled as a top priority by the World Health 
Organization and the Centers for Disease Control. The bacteria 
infects mainly at the hospital level in critical care and burn units, 
particularly immunocompromised patients 1-2.
• A plasmid containing various ADC genes 
were inserted into a non-pathogenetic
strain of E. coli.
• From these resulting colonies, protein 
expression was tested with non-induced 
and induced conditions.
• Confirm protein 
expression by gel 
electrophoresis 
(SDS-PAGE), 
molecular weight 
(MW) of ADC 
protein is ~ 40 kDa
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Quantitation of ADC concentration
• NaCl from elution buffer was removed through dialysis (10 kDa
cutoff) and concentrated using an Amicon centrifugal filter unit.
• Using UV-Vis spectrophotometry, the absorbance at 280 nm was 
measured to allow for [ADC] quantitation for calculations needed 
for crystal trays and steady state kinetics.
UV-Vis spectrum from ADC-30 concentration
• Crystals are grown at varying concentrations 
to determine if ADC variants  crystallize in 
the same known conditions as ADC-7
• Crystals were grown to be used in X-ray 
crystallography
Crystal tray for ADC-25
The reaction rate was determined 
for ADC inactivating a specific 
cephalosporin antibiotic, 
nitrocefin (NCF). Assay 
conditions: 2 nM ADC-30, 10 mM
NaPO4, pH 7.4, variable 
concentrations of NCF.
• After focused an X-ray beam hits the crystal, diffraction patterns 
result from the electron density in the protein crystal.
• The diffraction patterns can be used to  calculate a map of the 
electron density of the protein (and allow for structure 
determination).
Example of a diffraction 
pattern 3
Adapted from Goodman & Gilman's The Pharmacological Basis of 
Therapeutics, Ninth Edition
E. coli colonies plated on LB-
Kanamycin
Growth and Purification With Ion Exchange 
Chromatography
• 1 L LB-Kanamycin cultures were grown  and induced with IPTG
• Cultures were centrifuged and resulting cell pellet was stored at      
-80 oC.
• Resuspended cell pellets (25 mM MOPS, pH 6.5) were sonicated, 
centrifuged, and the supernatant was loaded on a carboxymethyl
(CM)-cellulose column at 4 oC.
• The column was washed with 25 mM MOPS, pH 6.5 and eluted 
with 25 mM MOPS, pH 6.5, 500 mM NaCl, leading to fractions 
containing the purified ADC protein.
Elution profile of ADC purification by CM-cellulose chromatography
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Acinetobacter-Derived Cephalosporinases (ADCs)
• A. baumannii contain class C β-lactamases called Acinetobacter-
Derived Cephalosporinases.
• New ADCs have been isolated from recently infected individuals, 
some of which have shown resistance to carbapenems.
• These new variants have slightly different sequences that may be 
responsible for structural changes in the enzyme, possibly 
providing the ADC enzyme with an improved ability to bind and 
inactivate antibiotics.
Steady State Kinetics
Crystal Tray Preparation
X-ray Crystallography
Argonne National Laboratory
• ADC-25 A200D/P220L/A 
insert
• ADC-30
• ADC-33
• ADC-162 (ADC-30 A221E)
• ADC-56
• ADC-68
• ADC-25 (ADC-30 T317N)
• ADC-33 G223D
• Dr. Wallar and Lab Members – Erin Fish, Micah Fernando
• Dr. Rachel Powers – GVSU
• Dr. Robert Bonomo and lab (Magda Taracila) – Louis Stokes 
Cleveland Dept. of Veteran Affairs Medical Center, Case Western 
Reserve University
• Dr. Fabio Prati and lab (Chiara Romagnoli and Emilia Caselli) –
Università di Modena e Reggio Emilia, Modena, Italy
• Advanced Photon Source (LS-CAT)
• National Institutes of Health
• McNair Program (GVSU)
Four of the variants have been purified through a one step CM-
cellulose method, resulting in about 50-80 mg of pure protein for each 
of the following variants.
• ADC-25 (A200D/P220L/A insert)
• ADC-30
• ADC-33
• ADC-162 (ADC-30 A221E)
Numerous crystal trays were set up for all variants and were in 
successful in growing crystals in three of them. 
• ADC-30
• ADC-33
• ADC-162 (ADC-30 A221E)
Successful expression of plasmids for 8 ADC variants:
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Competition kinetics were performed  to determine the Ki values for 
the ADC variants with MB076. This graph shows that MB076 binds 
and prevents ADC-30 from inactivating nitrocefin. Assay conditions: 
2 nM ADC-30, 10 mM NaPO4, pH 7.4, 60 μM NCF, variable 
concentrations of MB076.
X-ray crystallography performed at Argonne National Laboratory 
resulted in structures between 1.25 – 1.8 Å resolution. The following 
six structures were obtained:
▪ ADC-30 apo and ADC-30 with MB076 bound
▪ ADC-33 apo and ADC-33 with MB076 bound
▪ ADC-162 apo and ADC-162 with MB076 bound
NON / IND
Crystallization: Hanging Drop Technique
• Crystallize protein using
hanging drop vapor 
diffusion (0.1 M Succinate/ 
Phosphate/Glycine. pH 5.0)
• Crystals were soaked in a solution
containing drug/inhibitor amd
frozen using liquid N2
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ADC-30
Nitrocefin
(yellow)
Hydrolyzed product (red, 
482 nm)
